Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leiomyoma × relugolix × Clear all

Phase

Phase 3 5 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 21 Prostate Adenocarcinoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Leiomyoma 1 Adenocarcinoma 1

Interventions

telapristone acetate 10 ulipristal 3 vilaprisan 2 Mifepristone 2 Leuprolide 2 ulipristal acetate 1 relugolix 1 pirfenidone 1 estradiol, norethindrone drug combination 1 epigallocatechin gallate 1 elagolix 1 asoprisnil 1 Tea 1 Sugars 1 Norethindrone Acetate 1 Morphine 1 Methadone 1 Lidocaine 1 Estradiol 1 Embolization, Therapeutic 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01452659 2013-01-21

Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids

Takeda

Phase 2 Completed

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡